Skip to content

Clinical trials

Phase 2 Hyperinsulinism trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperinsulinism Phase: Phase 2 Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20081
20091
20101
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital of Philadelphia3
Jack Yanovski, M.D.1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
New York Medical College1
Rezolute1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperinsulinism8
Congenital Hyperinsulinism3
Hypoglycemia3
Obesity3
Diabetes Mellitus2
Glucose Metabolism Disorders2
Diabetes Mellitus, Type 21
Digestive System Diseases1
Dyslipidemias1
Hyperglycemia1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.